Clinical trial
EVL Plus Drug to Prevent Variceal Rebleeding
NCT00371943 · National Science and Technology Council, Taiwan, Other · Terminated
Key facts
| NCT number | NCT00371943 |
|---|---|
| Title | EVL Plus Drug to Prevent Variceal Rebleeding |
| Official title | A Controlled Trial of Ligation Plus Drug Vs. Drug Alone in the Prevention of Variceal Rebleeding |
| Lead sponsor | National Science and Technology Council, Taiwan, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bleeding |
| Intervention type | Procedure |
| Interventions | band ligation |
| Enrollment | 120 |
| Start date | Jul 1, 2001 |
| Completion | Mar 1, 2005 |
| First posted | Sep 4, 2006 |
| Last update posted | Sep 15, 2006 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: